經濟效益

Impact of a patient blood management monitoring and feedback programme on allogeneic blood transfusions and related costs. （開啟新視窗）

Kaserer A, Rössler J, Braun J, Farokhzad F, Pape HC, Dutkowski P, Plass A, Horisberger T, Volbracht J, Manz MG, Spahn DR

出處‎: Anaesthesia 2019;74(12):1534-41.

檢索‎: PubMed 31448406

DOI碼‎: 10.1111/anae.14816

https://www.ncbi.nlm.nih.gov/pubmed/31448406 （開啟新視窗）

Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia. （開啟新視窗）

Kaur MN, Arnold DM, Heddle NM, Cook RJ, Hsia C, Blostein M, Jamula E, Sholzberg M, Lin Y, Kassis J, Larratt L, Tinmouth A, Carruthers J, Li N, Liu Y, Xie F

出處‎: Blood Adv. 2022;6(3):785-92.

檢索‎: PubMed 34781363

DOI碼‎: 10.1182/bloodadvances.2021005627

https://pubmed.ncbi.nlm.nih.gov/34781363/ （開啟新視窗）

血液科

經濟效益

中文繁體（廣東話）

經濟效益

https://assetsnffrgf-a.akamaihd.net/assets/ct/2208d1720a/images/syn_placeholder_sqr.png

Impact of a patient blood management monitoring and feedback programme on allogeneic blood transfusions and related costs. （開啟新視窗）

Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia. （開啟新視窗）

聯絡本地醫院聯絡委員會代表

醫療資訊匯總

影片

經濟效益

Impact of a patient blood management monitoring and feedback programme on allogeneic blood transfusions and related costs. （開啟新視窗）

Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia. （開啟新視窗）

聯絡本地醫院聯絡委員會代表

醫療資訊匯總

影片

選擇你的語言

分享